Hormone therapy combination may benefit health without increasing cancer risk

December 22, 2017 by Sharita Forrest, University of Illinois at Urbana-Champaign
A team led by food science and human nutrition professor Zeynep Madak-Erdogan found that treating ovariectomized mice with a combination of conjugated estrogens and the drug bazedoxifene improved metabolism and prevented the weight gain often associated with low estrogen levels without posing increased risk to their reproductive tissues. Credit: L. Brian Stauffer

Treating ovariectomized mice with a combination of conjugated estrogens and the drug bazedoxifene triggers the expression of genes that improve metabolism and prevent weight gain – without stimulating the uterus and increasing risks of reproductive cancer, a new study suggests.

University of Illinois food science and human nutrition professor Zeynep Madak-Erdogan led a group of researchers who explored the effects of conjugated estrogens and bazedoxifene on the liver by analyzing gene transcription and the metabolism of about 150 chemicals in the blood. The findings were reported in a paper published in the online journal PLOS One.

Bazedoxifene is commonly prescribed in combination with conjugated estrogens to prevent postmenopausal osteoporosis. It is among a class of compounds known as selective estrogen receptor modulators, which bind to estrogen receptors and either promote or block their activity.

"Once women enter menopause and estrogens are lost, their metabolism is rewired, in the sense that they often start gaining weight, their bad cholesterol increases, their good cholesterol decreases and they may become pre-diabetic," Madak-Erdogan said. "If they are prescribed a combination of bazedoxifene and conjugated estrogens, these symptoms often improve."

"We wanted to see why this drug combination is helpful, so we used a genomewide approach where we looked at the gene expression profiles in the liver," Madak-Erdogan said. "Because the liver is a major organ in metabolic control and regulates many of the chemicals in the blood, we looked at blood serum composition as well."

The scientists fed 48 eight-week-old mice a in which 45 percent of the calories came from fat. To mimic the low-estrogen state of menopause, 40 of the mice had their ovaries removed when they reached 10 weeks old. The mice then were randomly divided into five groups, each of which was treated for six weeks with a different combination of conjugated estrogens and bazedoxifene.

The scientists measured the mice's food intake and body weight weekly, and performed MRIs before treatment and at four weeks post-treatment to measure each animal's whole body mass and lean body mass.

After the treatment period, the scientists euthanized the mice and weighed their adipose (fat) tissue, including their , which stores energy in the form of lipids; and their mesenteric and perirenal adipose tissues, two forms of abdominal fat associated with the development of type 2 diabetes, insulin resistance, inflammation and other obesity-related diseases.

Using liver samples from each treatment group, the scientists examined the expression of various genes within the mice's livers and measured the levels of nearly 150 metabolites in their blood, including cholesterol, free fatty acids and glucose.

Treatment with bazedoxifene and conjugated estrogens decreased the expression of genes along three parallel metabolic pathways that affect liver health – reducing lipid accumulation, levels of inflammation and reactive oxygen species pathways in the liver, Madak-Erdogan said.

The researchers found that eight metabolites associated with the weight and health of the liver were down-regulated by the estrogen supplements – including several metabolites known to be misregulated in people with nonalcoholic fatty disease.

"Treatment with conjugated estrogens and bazedoxifene also prevented the that is often associated with postmenopausal decreases in and consuming a high-fat diet," Madak-Erdogan said. "Animals in the treatment group had less fat mass and lower body weights than their peers in the control group. And their uteruses and mesenteric white adipose tissue weighed significantly less than those of their peers."

Recent studies suggesting that hormone replacement therapy increases women's risks of reproductive cancers have prompted physicians to exercise caution in prescribing hormones – despite evidence that HRT may improve women's metabolic functioning, lessen weight gain and lower their risks of serious health conditions such as cardiovascular disease and diabetes, Madak-Erdogan said.

"Although hormone therapy could reduce postmenopausal gain and many serious metabolic problems, physicians tend to avoid prescribing it because of concerns about elevating women's risks of reproductive cancers," Madak-Erdogan said. "Our study suggests that the combination of conjugated estrogens and bazedoxifene could improve metabolism without posing increased risk to the reproductive tissues."

Explore further: Scientists identify genes that disrupt response to breast cancer treatment

More information: Karen Lee Ann Chen et al. Bazedoxifene and conjugated estrogen combination maintains metabolic homeostasis and benefits liver health, PLOS ONE (2017). DOI: 10.1371/journal.pone.0189911

Related Stories

Scientists identify genes that disrupt response to breast cancer treatment

September 7, 2016
Scientists may have unlocked the genetic code that determines why many patients with estrogen receptor-positive breast cancer fail to respond to the widely used drug tamoxifen.

FDA OKs drug to treat hot flashes in menopausal women

October 4, 2013
(HealthDay)—Pfizer Inc. says it has gained U.S. approval for a drug designed to treat menopause-related hot flashes and potentially prevent osteoporosis in postmenopausal women who have a uterus.

Tamoxifen protects against obesity-related metabolic disorders

May 11, 2017
Tamoxifen, a selective estrogen receptor modulator, is the gold standard for endocrine treatment of estrogen-receptor positive breast cancer. Tamoxifen is also known to have metabolic effects. A new study in The American ...

Yerba mate's beneficial effects on cellular energy and lipid metabolism linked to weight

November 14, 2017
Researchers have shown that use of the dietary supplement yerba mate over an extended period had significant effects on body weight and weight gain and was associated with lower levels of blood lipids and insulin in obese ...

Estrogen in the brain prevents obesity and glucose intolerance during menopause in lab animal study

July 18, 2017
Researchers at the University of Cincinnati (UC) have found that adding estrogen in the brain may improve health in obese females after menopause.

Recommended for you

Experts caution study on plastics in humans is premature

October 23, 2018
Scientists in Austria say they've detected tiny bits of plastic in people's stool for the first time, but experts caution the study is too small and premature to draw any credible conclusion.

Can organic food help you reduce your risk of cancer? A new study suggests the answer may be yes

October 22, 2018
To reduce your risk of cancer, you know you should quit smoking, exercise regularly, wear sunscreen, and take advantage of screening tests. New research suggests another item might be added to this list: Choose organic foods ...

A topical gel that can prevent nerve damage due to spraying crops with pesticides

October 22, 2018
A team of researchers affiliated with several institutions in India has developed a topical get that can be used by farmers to prevent nerve damage due to chemical crop spraying. In their paper published in the journal Science ...

Moderate exercise before conception resulted in lower body weight, increased insulin sensitivity of offspring

October 22, 2018
Men who want to have children in the near future should consider hitting the gym.

Modern conflict: Screen time vs. nature

October 22, 2018
Even rural kids today spend more time in front of screens and less time outdoors, according to a new study of middle-school students in South Carolina.

Community health workers can reduce hospitalizations by 65 percent and double patient satisfaction with primary care

October 22, 2018
Community health workers—trusted laypeople from local communities who help high-risk patients to address social issues like food and housing insecurity—can help reduce hospital stays by 65 percent and double the rate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.